ArticleJournal of clinical immunology2026

Anifrolumab to Treat Severe Hepatic Involvement in a De Novo IFIH1 Mutation.

Micol Romano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.